Lupin Q4 Results: Profit More Than Doubles, Surpasses Estimates
Lupin Ltd has reported a stellar financial performance for the fourth quarter (Q4) of FY25, with net profit surging 115% year-on-year (YoY) to ₹772 crore. The pharmaceutical giant has exceeded analysts’ expectations, driven by strong sales growth in North America and India. Financial Highlights Market Performance & Growth Drivers Lupin’s North American sales surged to…
